To compare the clinical outcomes between using telecobalt plus low-dose-rate intracavitary brachtherapy (telecobalt+LDR) and telecobalt alone (Telecobalt) for treatment of invasive uterine cervical carcinoma

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     110    27

Abstract

AA

https://doi.org/10.38103.21.28

References

A

Published 16-02-2025
Fulltext
PDF (Tiếng Việt)     110    27
Language
Issue No. 21 (2014)
Section Original article
DOI 10.38103.21.28
Keywords

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital

Ai, N. T., Hiep, P. N., Tuong, P. N., Dung, N. V., Duy, P. C., Chau, C. K., … Dung, N. C. (2025). To compare the clinical outcomes between using telecobalt plus low-dose-rate intracavitary brachtherapy (telecobalt+LDR) and telecobalt alone (Telecobalt) for treatment of invasive uterine cervical carcinoma. Journal of Clinical Medicine Hue Central Hospital, 6(21), 202–209. https://doi.org/10.38103.21.28